LEKPHARM QUALITY IS AFFORDABLE! LEKPHARM is a full circle - - PowerPoint PPT Presentation
LEKPHARM QUALITY IS AFFORDABLE! LEKPHARM is a full circle - - PowerPoint PPT Presentation
LEKPHARM QUALITY IS AFFORDABLE! LEKPHARM is a full circle manufacturing pharmaceutical company that operates according to GMP standarts Developing Studies Registration Manufacturing Quality control Distribution
LEKPHARM is a full circle manufacturing pharmaceutical company that operates according to GMP standarts Developing Studies Registration Manufacturing Quality control Distribution
In 2006 «Lekpharm» received license to perform pharmaceutical activities
History
2007 – GMP certificate for tablets manufacturing
History
2010 – renewal of GMP certificate for manufacturing tablets 2013 – renewal of GMP certificate for manufacturing tablets
History
2014 – international GMP certificate that complies Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S)
History
2015 – GMP certificate for manufacturing powders in sachet bags
History
2015 – GMP certificate for manufacturing sterile injections in ampoules
History
2011 – ISO 14001 certificate 2014 – ISO 14001 certificate renewal
History
2006 – laboratory accreditation under ISO 17025 2009, 2014 – ISO 17025 accreditation renewal
История
«Best enterpreneur of Republic of Belarus» in medical field – 2009, 2010, 2011 Decree of the President of Republic of Belarus №296 от 01.07.2014 Lekpharm became a member of State Honor Board «Best export company of 2014» in medical field
Awards
Manufacturing
Cardiological medicines Medicines for treatment:
Musculoskeletal system GIT General anesthesia Antiviral, symptomatic Mineral-vitamin complexes
Forms: tablets capsules powders in sachets ampoules
Quality
Main priority – guarantee the expected level and stability of the quality of products, its safety and efficiency.
Russia India China Austria Czech Rep Great Britain Latin America Germany Denmark Croatia Spain
Careful selection of supply partners
Lekpharm – quality is affordable!
Automatic control of production process parameters Control over the proper operation of the equipment is carried out by highly qualified personnel
Manufacturing
Equipment
Tablets Capsules Sachet bags Ampoules Laboratory Contract Manufacturing
The production capacity of the enterprise is 1 billion units per year for all forms combined
Capacity
Manufacturing building
Total area of the premises – 5582,9 m² Manufacturing area – 793,2 m² Warehouse area – 1600,6 m² Quality control department – 322,7 m² Chemical laboratory - 185,6 m² Microbiological laboratory - 137,1 m²
Departments:
- Quality assesment – 5
- Quality control – 49
- Validation – 4
- Mechanics – 12
- Manufacturing – 111
- Research and Development – 21
- Warehouse – 7
- Distibution – 31
- Administration - 81
325 employees
Key financial data 2016
Manufactured: 49,950 mln USD, growth rate 126,6%
Supplied:
41,526 mln USD, growth rate 131,6%
Exported:
5,653 mln USD
№ Company 2016 year Volume sales sum, USD
1 Belmedpreparaty 82 652 217 2 Borisovskiy Zavod Medicinskikh Preparatov 61 400 141 3 Lekpharm 42 856 058 4 NOVARTIS 29 208 750 5 Pharmland Group 25 669 972 6 SANOFI 25 540 888 7 TAKEDA 22 356 876 8 PHARMTECHNOLOGY 21 942 863 9 GEDEON RIHTER 20 778 128 10 GSK 20 592 574
Lekpharm — one of the leading enterprises in Belarus
Quality control studies: 2013 year – 81959, 2014 year – 96629, 2015 year – 126565, 2016 year – 137 748
Annual report
Dosage form Produced 2013 year Produced 2014 year Produced 2015 year Produced 2016 year mln. units Growth rate % mln. units Growth rate % mln. units Growth rate % mln. units Growth rate % Tablets
473,1 119 546,4 115,5 606,3 130,0 519,9 85,7
Capsules
75,3 106 96,2 127,8 143,2 149,2 61,8 43,2
Sachet
5,5 440 8,7 157,9 14,9 171,3 12,1 6,7
Ampoules
- 0,2
- 1,9
950
The list of medicines
57 INN 11 INN
2007 2016
AMBROXOL ALFAHOLIN (choline alfoscerate) HYDROCHLOROTHIAZ IDE CLOPIDOGREL LF MOXONIDIN LF TAMSULOSIN LF AMLODIPINE AMBROXOL GLICLAZID MV LEVOCETIRIZIN LF MOLSIDOMIN LF TRI-ZIDIN M (trimetazidine) ARPETOL (umifenovir) AMPLODIPINE GRIPOMIX LIZITAR LF NEIROVIT FENSPIRID LF VIASIL (sildenafil) AMLOTESIN (perindopril/amlodip ine) DEZLORATADIN LF LIPROMAK LF (ATORVASTATIN) NISIT (nimesulide) FIGURIN (orlistat) VINNER LF (vinpocetine) ARPETOL DEXKETOPROFEN LF LOVASTATIN NITROGLYCERIN CHLOROPYRAMIN LF DROTAVERINE ASC DROTAVERINE MAGNELEK NIFUROXAZID LF HONDROMED (chondroitin sulfate) NITROGLYCERIN BETAHISTINUM INDALONG (indapamide) MEBEVERIN LF NITCERGOLIN LF HONDROMED PLUS (chondroitin sulfate+glucosamin) OMEPRAZOLE BICARD-LF (bisoprolol) INDATENSIN (perindopril/indapamid e) MEKSILEK OMEPRAZOLE CERALIN (citicoline) HONDROMED (chondroitin sulfate) VIASIL (sildenafil) INTRACONAZOL MELOXICAM LF ORVIKOLD EKVAPRIL ENALAPRIL VINNER LF (vinpocetine) KETONOF LF MELDONAT PERINDOPRIL LF ESFOLIP ABC of Health HEPATOLEK KETOPROFEN LF METOPROLOL RAMILONG (ramipril) RAMILONG PLUS
(ramipril+hydrochlorothia zide)
We export in 7 countries | 28 Distributors | 87 foreign product registrations | Representative offices in Moldova, Kazakhstan Lithuania Moldova Georgia Azerbaijan Ukraine Russia Vietnam Kazakhstan Kyrgyzstan Uzbekistan
Expanding capacities in 2016
June 2015 Lekpharm started manufacturing of sterile injections in ampoules Innovative equipment and modern technology allow to reach capacity of 150 mln ampoules per year
Plans for 2017
In 2017 Lekpharm is going to modernize and increase capacity of manufacturing solid drug forms in tablets, capsules and powders
R&D of generics in 2017
R&D - 22 generics at BE stage – 10 medicines in the registration process – 7 medecines in the registration process abroad – 29 medicines in 2017-2018 R&D pipeline – more than 40 medicines
LEKPHARM JLLC
Thank you for the attention!
Belarus Logoisk, 2A Minskaya str. T: +375 25 606 90 12 email:
- ffice@Lekpharm.by
marchenko@Lekpharm.by
- stapchik@lekpharm.by